- Home
- FRD vs MBOT Comparison
FRD vs MBOT Comparison
Compare FRD & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRD | MBOT |
|---|---|---|
| Founded | 1965 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.0M | 134.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FRD | MBOT |
|---|---|---|
| Price | $19.99 | $2.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.75 |
| AVG Volume (30 Days) | 15.2K | ★ 1.3M |
| Earning Date | 02-06-2026 | 11-12-2025 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | ★ 43.48 | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $510,450,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,119.61 |
| P/E Ratio | $11.97 | ★ N/A |
| Revenue Growth | ★ 8.72 | N/A |
| 52 Week Low | $12.24 | $1.25 |
| 52 Week High | $23.50 | $4.67 |
Technical Indicators
Market Signals| Indicator | FRD | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 48.17 | 49.99 |
| Support Level | $19.19 | $2.06 |
| Resistance Level | $20.05 | $2.18 |
| Average True Range (ATR) | 0.56 | 0.10 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 35.87 | 77.78 |
Price Performance
Historical ComparisonAbout FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.